Lenz Therapeutics Stock Alpha and Beta Analysis
| LENZ Stock | 12.88 0.09 0.69% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as LENZ Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in LENZ Therapeutics over a specified time horizon. Remember, high LENZ Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to LENZ Therapeutics' market risk premium analysis include:
Beta 0.92 | Alpha (0.78) | Risk 5.49 | Sharpe Ratio (0.17) | Expected Return (0.95) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out LENZ Therapeutics Analysis, LENZ Therapeutics Valuation, LENZ Therapeutics Correlation, LENZ Therapeutics Hype Analysis, LENZ Therapeutics Volatility, LENZ Therapeutics Price History and analyze LENZ Therapeutics Performance. LENZ Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. LENZ Therapeutics market risk premium is the additional return an investor will receive from holding LENZ Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in LENZ Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate LENZ Therapeutics' performance over market.| α | -0.78 | β | 0.92 |
LENZ Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of LENZ Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how LENZ Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.LENZ Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how LENZ Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading LENZ Therapeutics shares will generate the highest return on investment. By understating and applying LENZ Therapeutics stock market price indicators, traders can identify LENZ Therapeutics position entry and exit signals to maximize returns.
LENZ Therapeutics Return and Market Media
The median price of LENZ Therapeutics for the period between Mon, Nov 17, 2025 and Sun, Feb 15, 2026 is 18.14 with a coefficient of variation of 27.29. The daily time series for the period is distributed with a sample standard deviation of 5.58, arithmetic mean of 20.45, and mean deviation of 4.92. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | LENZ Therapeutics Stock Price Down 5.1 percent - Time to Sell - MarketBeat | 12/23/2025 |
2 | Acquisition by Evert Schimmelpennink of 358100 shares of LENZ Therapeutics at 16.0 subject to Rule 16b-3 | 01/02/2026 |
3 | Acquisition by Shawn Olsson of 10000 shares of LENZ Therapeutics at 2.08 subject to Rule 16b-3 | 01/06/2026 |
4 | INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ | 01/08/2026 |
5 | A Look At LENZ Therapeutics Valuation After VIZZ Launch Momentum And New Lunatus Agreement | 01/13/2026 |
6 | LENZ Therapeutics and Sarah Jessica Parker announce the launch of Make it VIZZable, the VIZZ consumer campaign | 01/14/2026 |
7 | William Blair Maintains LENZ Therapeutics With Buy Rating, Announces Target Price 58 - | 01/30/2026 |
8 | Acquisition by Chevallard Daniel R. of 200000 shares of LENZ Therapeutics at 15.05 subject to Rule 16b-3 | 02/05/2026 |
9 | LENZ Therapeutics Stock Analysis Eyeing A 295 percent Upside In The Biotech Arena - DirectorsTalk Interviews | 02/13/2026 |
About LENZ Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including LENZ or other stocks. Alpha measures the amount that position in LENZ Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2025 | 2026 (projected) | Dividend Yield | 0.5 | 0.45 | 0.4 | Price To Sales Ratio | 8.21 | 7.39 | 6.57 |
LENZ Therapeutics Investors Sentiment
The influence of LENZ Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in LENZ. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to LENZ Therapeutics' public news can be used to forecast risks associated with an investment in LENZ. The trend in average sentiment can be used to explain how an investor holding LENZ can time the market purely based on public headlines and social activities around LENZ Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
LENZ Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for LENZ Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average LENZ Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on LENZ Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards LENZ Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, LENZ Therapeutics' short interest history, or implied volatility extrapolated from LENZ Therapeutics options trading.
Build Portfolio with LENZ Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for LENZ Stock Analysis
When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.